Treatment for pancreatic cancer patients is challenging and not well defined, especially for patients with disease progression or adverse events seen after initial treatment. Studies suggest that, after diagnosis, about 22% of pancreatic cancer patients, regardless of their clinical stage of cancer, receive no treatment.
The incidence of pancreatic cancer is increasing worldwide, and the cases are seen to double compared to the past few decades. Compared to other major cancers, the mortality rate is very high due to the late diagnosis and higher progression rate.
The overall 5-year survival is less than 5% for pancreatic patients in advanced or metastatic stages...
